ChurchillD.N., TaylorD.W., KeshaviahPR, for the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes.J Am Soc Nephrol.1996; 7: 198–207.
2.
BlakeP.G.Critique of the Canada-U.S.A. (CANUSA) peritoneal dialysis study.Perit Dial Int.1996; 16: 243–45.
3.
National Kidney Foundation Dialysis Outcomes Quality Initiative, Peritoneal Dialysis Adequacy Work Group.Clinical practice guidelines for peritoneal dialysis adequacy.Am J Kidney Dis.1997; 30(Suppl 2): S67–136.
4.
LoW.K., JiangY., ChengS.W., ChengI.K.P.Survival of CAPD patients in a center using three 21iter exchanges as a standard regime.Perit Dial Int.1996; 16(Suppl 1): S163–6.
5.
FentonS.S.A., SchaubelD.E., DesmeulesM., MorrisonH.I., MaoY., CoplestonP.Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates.Am J Kidney Dis.1997; 30: 334–42.
6.
BlakeP.G., BloembergenW., FentonS.S.A.Changes in the demographics and prescription of peritoneal dialysis during the past decade.Am J Kidney Dis.1998; 32: S44–51.
7.
United States Department of Health and Human Services, Public Health Service, National Institutes of Health.USRDS 1997 Annual Data Report.Bethesda, MD: United States Renal Data System; 1997.
8.
BloembergenW.E., OrzolS., PortF.K.A description of the delivery of peritoneal dialysis in the U.S. (Abstract).J Am Soc Nephrol.1997; 8: 1276A.
9.
RoccoM.V., FlaniganM.J., ProwantB., FrankenfieldD., FrederickP.1996 peritoneal dialysis core indicators study (PD-CIS): CAPD prescription and adequacy data (Abstract).J Am Soc Nephrol.1997; 8: 289A.
10.
BlakeP.G., MightonL., JindalK., FentonSSA, for the CORREPREX Study Group. Changes in CAPD prescription practices in Canada 1996–1998 (Abstract).Perit Dial Int.1999: 19(Suppl 1): S14.
11.
BlakeP.G., MightonL., JindalK., FentonSSA, for the CORREPREX Study Group. A description of automated PD (APD) prescription practices in Canada 1996–1998 (Abstract).Perit Dial Int.1999: 19(Suppl 1): S14.
12.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PageD. for the Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients.J Am Sac Nephral.1998; 9: 1285–92.
13.
BlakeP.G.What is the problem with high transporters?Perit Dial Int.1997; 17: 317–20.
14.
TzamaloukasA.H., SaddlerM.C., MurataG.H., MalhoutraD., SenaP., SimonD.Symptomatic fluid retention in patients on continuous peritoneal dialysis.J A Sac Nephral.1995; 6: 198–206.
15.
MistryC.D., GokalR., PeersE, and the MIDAS Study Group. A randomized multicenter trial comparing isomolar icodextrin with hyperosmolar glucose solutions in CAPD.Kidney Int.1994; 46: 496–503.
16.
LowrieE.G.Conceptual model for a core pathobiology of uremia with special reference to anemia, malnourishment and mortality among dialysis patients.Semin Dial.1997; 10: 115–29.
17.
HanD.S., LeeS.W., KangS.W., ChoiK.H., LeeH.Y., ChoE.Y.Factors affecting low values of serum albumin in CAPD patients. In: KhannaR., ed. Advances in Peritoneal Dialysis, 1996; 12: 288–92.
18.
YeunJ.T., KaysenaAAcute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients.Am J Kidney Dis.1997; 30: 923–27.
19.
Blakepa, Flowerdewa, BlakeR.M., OreopoulosDa8erum albumin in patients on continuous ambulatory peritoneal dialysis -Predictors and correlations with outcomes.J Am Soc Nephrol.1993; 3: 1501–07.
20.
BergströmJ., HeimbürgerO., LindholmB., QureshiA.R.Elevated serum C-reactive protein (CRP) is a strong predictor of increased mortality and low serum albumin in hemodialysis patients [Abstract].Blood Purif.1995; 13: 849–50.
21.
BergströmJ., LindholmB.Malnutrition, cardiac disease and mortality: An integated point of view.Am J Kidney Dis.1998; 32: 834–41.
22.
ChertowaM, LingJ., LewN.L., LazarusJ.M., LowrieEaThe association of intradialytic peritoneal nutrition administration with survival in hemodialysis patients.Am J Kidney Dis.1994; 24: 912–20.
23.
KoppleJ.D., BernardD., MessanaJ., 8wartzR., BergströmJ., LindholmB.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int.1995; 47: 1148–57.
24.
BloembergenW.E., PortF.K., MaugerE.A., WolfeR.A.A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol.1995; 6: 177–83.
25.
VoneshE., MoranJ.Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis.J Am Soc Nephrol.1999; 10: 354–65.
26.
MoranJ.Changes in the dose of peritoneal dialysis: Have these independently affected outcomes?Am J Kidney Dis.1998; 32(Suppl 4): 852–7.